Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126564832 | 12656483 | 2 | F | 201608 | 20160817 | 20160816 | 20160819 | EXP | US-INCYTE CORPORATION-2016IN004990 | INCYTE | 80.36 | YR | M | Y | 0.00000 | 20160819 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126564832 | 12656483 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | N | U | 1402630BB | 202192 | 5 | MG | TABLET | ||||
| 126564832 | 12656483 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | N | U | 202192 | 5 | MG | TABLET | |||||
| 126564832 | 12656483 | 3 | C | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 4 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 5 | C | COLCHICINE. | COLCHICINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 7 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | 0 | ||||||||||
| 126564832 | 12656483 | 9 | C | APAP/CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 | ||||||||||||
| 126564832 | 12656483 | 10 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 126564832 | 12656483 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126564832 | 12656483 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126564832 | 12656483 | 13 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126564832 | 12656483 | 14 | C | TORSEMIDE. | TORSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126564832 | 12656483 | 1 | Myelofibrosis |
| 126564832 | 12656483 | 3 | Product used for unknown indication |
| 126564832 | 12656483 | 4 | Product used for unknown indication |
| 126564832 | 12656483 | 5 | Product used for unknown indication |
| 126564832 | 12656483 | 6 | Product used for unknown indication |
| 126564832 | 12656483 | 7 | Product used for unknown indication |
| 126564832 | 12656483 | 8 | Product used for unknown indication |
| 126564832 | 12656483 | 9 | Product used for unknown indication |
| 126564832 | 12656483 | 10 | Product used for unknown indication |
| 126564832 | 12656483 | 11 | Product used for unknown indication |
| 126564832 | 12656483 | 12 | Product used for unknown indication |
| 126564832 | 12656483 | 13 | Product used for unknown indication |
| 126564832 | 12656483 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126564832 | 12656483 | HO |
| 126564832 | 12656483 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126564832 | 12656483 | Arthritis | |
| 126564832 | 12656483 | Bedridden | |
| 126564832 | 12656483 | Death | |
| 126564832 | 12656483 | Malnutrition | |
| 126564832 | 12656483 | Spleen disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126564832 | 12656483 | 1 | 20150213 | 0 | ||
| 126564832 | 12656483 | 2 | 201502 | 20160815 | 0 |